Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Nakanishi

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Kidney International Reports|May 27, 2026
Balancing Benefits and Risks of Rituximab in Pediatric Idiopathic Nephrotic Syndrome: The Critical Role of AgeKoichi Nakanishi
Nihon Jinzo Gakkai Shi|July 2, 2015
[Alport syndrome]Koichi Nakanishi, Norishige Yoshikawa
Pediatrics International : Official Journal of the Japan Pediatric Society|October 3, 2003
Genetic disorders of human congenital anomalies of the kidney and urinary tract (CAKUT)Koichi Nakanishi, Norishige Yoshikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 13, 2002
[Hereditary nephritis]Koichi Nakanishi, Norishige Yoshikawa
Nihon Jinzo Gakkai Shi|April 22, 2009
[RPGN in children]Koichi Nakanishi, Norishige Yoshikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 10, 2006
[Congenital nephrotic syndrome: Pathogenesis, pathophysiology, and therapy]Norishige Yoshikawa, Koichi Nakanishi
Journal of Bioscience and Bioengineering|December 17, 2013
Culture of a high-chlorophyll-producing and halotolerant Chlorella vulgarisKoichi Nakanishi, Keiji Deuchi
Nihon Jinzo Gakkai Shi|November 19, 2013
[Basic research and clinical aspect in ARPDK: new insight]Koichi Nakanishi, Norishige Yoshikawa
Pediatric Nephrology (Berlin, Germany)|February 17, 2021
Non-immunosuppressive therapies for childhood IgA nephropathyYuko Shima, Koichi Nakanishi, Norishige Yoshikawa
Pediatric Nephrology (Berlin, Germany)|February 19, 2026
Response to letter: The "Balance Point" of serum creatinine: methodological concerns on peak timing and selection biasWataru Shimabukuro, Tomohide Yoshida, Koichi Nakanishi
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Kidney International Reports|May 27, 2026
Balancing Benefits and Risks of Rituximab in Pediatric Idiopathic Nephrotic Syndrome: The Critical Role of AgeKoichi Nakanishi
Nihon Jinzo Gakkai Shi|July 2, 2015
[Alport syndrome]Koichi Nakanishi, Norishige Yoshikawa
Pediatrics International : Official Journal of the Japan Pediatric Society|October 3, 2003
Genetic disorders of human congenital anomalies of the kidney and urinary tract (CAKUT)Koichi Nakanishi, Norishige Yoshikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 13, 2002
[Hereditary nephritis]Koichi Nakanishi, Norishige Yoshikawa
Nihon Jinzo Gakkai Shi|April 22, 2009
[RPGN in children]Koichi Nakanishi, Norishige Yoshikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 10, 2006
[Congenital nephrotic syndrome: Pathogenesis, pathophysiology, and therapy]Norishige Yoshikawa, Koichi Nakanishi
Journal of Bioscience and Bioengineering|December 17, 2013
Culture of a high-chlorophyll-producing and halotolerant Chlorella vulgarisKoichi Nakanishi, Keiji Deuchi
Nihon Jinzo Gakkai Shi|November 19, 2013
[Basic research and clinical aspect in ARPDK: new insight]Koichi Nakanishi, Norishige Yoshikawa
Pediatric Nephrology (Berlin, Germany)|February 17, 2021
Non-immunosuppressive therapies for childhood IgA nephropathyYuko Shima, Koichi Nakanishi, Norishige Yoshikawa
Pediatric Nephrology (Berlin, Germany)|February 19, 2026
Response to letter: The "Balance Point" of serum creatinine: methodological concerns on peak timing and selection biasWataru Shimabukuro, Tomohide Yoshida, Koichi Nakanishi
Pageof 22